Summary
- Current Price
- As of today, ZNTL price is $5.11, up +11.82% on
- Current Price All-Time High
- ZNTL price is currently -94.14% below its historical high of $87.19 set on
- Market Cap
- ZNTL current market cap is $364M, up +250.19% over the past 365 days
- PE Ratio
- ZNTL PE ratio is unknown
- Revenue
- ZNTL current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for ZNTL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Zentalis Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ZNTL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | zentalis.com |
| Employees | 166 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.11 | ||
| Price, 1D Change | +11.82% | |
| $364M | ||
| - | ||
| - | ||
| 2.08 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.91 | ||
| EPS, 1Y Change | +18.26% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.91 | ||
| EPS Estimate | N/A | -$1.74 |
| EPS Est. Change | N/A | +8.97% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $5.11 | ||
| Price Target | - | $5.50 |
| Price Tgt. Change | - | +7.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.40 | -$2.33 | +2.87% | |
| -$1.98 | -$1.91 | +3.89% | |
| -$1.74 | N/A | +8.97% | |
| -$1.56 | N/A | +18.43% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $40.62M | $67.43M | +66.00% | |
| - | $0.00 | - | |
| - | N/A | - | |
| $21.42M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +254.86% | ||
| -81.42% | ||
| +250.19% | ||
| -81.27% | ||
| -100.00% | ||
| 0.00% | ||
| +18.26% | ||
| +57.43% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $5.11 | ||
| $2.78 | ||
| $4.12 | ||
| $3.22 | ||
| $4.17 | ||
| $0.25 | ||
| 2.08 | ||
| $0.40 | ||
| 63.61 | ||
| 81.94% | ||
| 127.52% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.91 | ||
| $0.00 | ||
| - | ||
| -$145.01M | ||
| - | ||
| -$137.06M | ||
| - | ||
| -$145.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.93 | ||
| 6.93 | ||
| - | ||
| - | ||
| -3.53 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.99 | ||
| -1.31 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $216.20M | ||
| $245.89M | ||
| $288.97M | ||
| $253.19M | ||
| $72.76M | ||
| $36.56M | ||
| $39.58M | ||
| $3.87M | ||
| $7.21M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $137.06M | ||
| $145.01M | ||
| $0.00 | ||
| $0.00 | ||
| $739.00K | ||
| $0.00 | ||
| $442.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$125.25M | ||
| $131.62M | ||
| -$4.28M | ||
| $0.00 | ||
| -$125.25M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Guggenheim | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with ZNTL
FAQ
What is the ticker symbol for Zentalis Pharmaceuticals, Inc.?
The ticker symbol for Zentalis Pharmaceuticals, Inc. is NASDAQ:ZNTL
Does Zentalis Pharmaceuticals, Inc. pay dividends?
No, Zentalis Pharmaceuticals, Inc. does not pay dividends
What sector is Zentalis Pharmaceuticals, Inc. in?
Zentalis Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Zentalis Pharmaceuticals, Inc. in?
Zentalis Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Zentalis Pharmaceuticals, Inc. based in?
Zentalis Pharmaceuticals, Inc. is headquartered in United States
When did Zentalis Pharmaceuticals, Inc. go public?
Zentalis Pharmaceuticals, Inc. initial public offering (IPO) was on April 3, 2020
Is Zentalis Pharmaceuticals, Inc. in the S&P 500?
No, Zentalis Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Zentalis Pharmaceuticals, Inc. in the NASDAQ 100?
No, Zentalis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Zentalis Pharmaceuticals, Inc. in the Dow Jones?
No, Zentalis Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Zentalis Pharmaceuticals, Inc. last earnings report?
Zentalis Pharmaceuticals, Inc.'s most recent earnings report was on May 12, 2026
When does Zentalis Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Zentalis Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- ZNTL Official Website zentalis.com
- ZNTL Profile on Yahoo Finance finance.yahoo.com/quote/ZNTL
- ZNTL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zntl